We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Global pharma bosses vow to put science first in race for Covid-19 vaccine

Tue, 8th Sep 2020 11:52

(Sharecast News) - The bosses of nine of the world's largest pharmaceutical companies pledged not to put commercial interests ahead of safety in the race to find a vaccine for Covid-19.
Chief executive officers of nine of the front-runners in efforts to develop a vaccine, AstraZeneca, BioNTech SE, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Moderna, Novavax, Pfizer and Sanofi made their vow public through a joint letter.

They committed themselves not to pursue short-cuts in the development of the vaccines nor to seek regulatory approval before a vaccine candidate's efficacy and safety had first been proven in a large scale trial.

-- More to follow --

Related Shares

More News

AstraZeneca, Amgen Report Positive Tezepelumab Study Results

AstraZeneca, Amgen Report Positive Tezepelumab Study Results

Today 14:27

European Regulator Recommends GlaxoSmithKline's Dostarlimab Approval

European Regulator Recommends GlaxoSmithKline's Dostarlimab Approval

Today 14:19

GSK Covid-19 monoclonal treatment shows potential benefit for older patients

(Sharecast News) - A phase two clinical study on GlaxoSmithKline's monoclonal antibody treatment against Covid-19 revealed a "potentially important" benefit in reducing respiratory failure in patients aged 70 or older.

25 Feb 21 19:21

GlaxoSmithKline To Amend Covid-19 Treatment Study To Confirm Findings

GlaxoSmithKline To Amend Covid-19 Treatment Study To Confirm Findings

25 Feb 21 12:23

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.